SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000927016-01-503721
Filing Date
2001-11-13
Accepted
2001-11-13 00:00:00
Documents
5
Period of Report
2001-09-29

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.txt 10-Q 76604
3 BY-LAWS dex31.txt EX-3.1 30077
4 RAUSCHER EMPLOYMENT LETTER dex102.txt EX-10.2 20997
5 COHEN EMPLOYMENT LETTER dex103.txt EX-10.3 16246
6 LABAUDINERE EMPLOYMENT LETTER dex105.txt EX-10.5 16282
  Complete submission text file 0000927016-01-503721.txt   162211
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-10824 | Film No.: 1784226
SIC: 2835 In Vitro & In Vivo Diagnostic Substances